Mutations in gyrA and parC associated with resistance to fluoroquinolones in epidemiologically defined clinical strains of Acinetobacter baumannii

Saved in:
Bibliographic Details
Published inJournal of antimicrobial chemotherapy Vol. 51; no. 1; pp. 177 - 180
Main Authors Wisplinghoff, Hilmar, Decker, Mathias, Haefs, Christiane, Krut, Oleg, Plum, Georg, Seifert, Harald
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.01.2003
Oxford Publishing Limited (England)
Subjects
Acinetobacter
Acinetobacter baumannii - drug effects
Acinetobacter baumannii - genetics
Acinetobacter baumannii - isolation & purification
Acinetobacter Infections - drug therapy
Acinetobacter Infections - epidemiology
Acinetobacter Infections - microbiology
Anti-Infective Agents - pharmacology
DNA Gyrase - genetics
DNA Topoisomerase IV - genetics
Drug Resistance, Multiple, Bacterial - genetics
Europe - epidemiology
Fluoroquinolones
Humans
Microbial Sensitivity Tests - statistics & numerical data
Mutation - physiology
resistance
United States - epidemiology
United States
Europe
Online AccessGet full text

Cover

More Information
Bibliography:istex:EF4F8C03727CF3006AAC16B76A08EBDB3267F72F
ark:/67375/HXZ-C6ZNLNZV-F
local:dkf254
SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0305-7453
1460-2091
1460-2091
DOI:10.1093/jac/dkf254